Open-label dose-finding trial of buprenorphine implants (Probuphine) for treatment of heroin dependence.

[1]  A. Byrne,et al.  Data do not support buprenorphine as a first-line treatment for addiction. , 2007, The American journal of psychiatry.

[2]  G. Bigelow,et al.  Evaluation of a transdermal buprenorphine formulation in opioid detoxification. , 2007, Addiction.

[3]  S. Ripa,et al.  Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study. , 2007, Clinical therapeutics.

[4]  G. Perugi,et al.  Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients. , 2007, Journal of substance abuse treatment.

[5]  C. Rück,et al.  A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial. , 2007, The American journal of psychiatry.

[6]  J. Bell,et al.  Retention and attendance with supervised buprenorphine treatment: a case-note review. , 2006, Drug and alcohol review.

[7]  G. Bigelow,et al.  An injection depot formulation of buprenorphine: extended bio-delivery and effects. , 2006, Addiction.

[8]  R. Sittl.  Transdermal buprenorphine in cancer pain and palliative care , 2006, Palliative medicine.

[9]  T. V. Antonova,et al.  Co-Morbidity of Infectious and Addictive Diseases in St. Petersburg and the Leningrad Region, Russia , 2005, European Addiction Research.

[10]  B. Sproule,et al.  Buprenorphine , 2005, Clinical pharmacokinetics.

[11]  N. Clark,et al.  Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue? , 2005, Addiction.

[12]  Matthew Hickman,et al.  Global overview of injecting drug use and HIV infection among injecting drug users , 2004, AIDS.

[13]  J. Tignol,et al.  French field experience with buprenorphine. , 2004, The American journal on addictions.

[14]  G. Bigelow,et al.  Open-label trial of an injection depot formulation of buprenorphine in opioid detoxification. , 2004, Drug and alcohol dependence.

[15]  M. Torrens,et al.  Characteristics of Heroin Addicts Entering Methadone Maintenance Treatment: Quality of Life and Gender , 2004, Substance use & misuse.

[16]  Jason M. White,et al.  Opioid effects and opioid withdrawal during a 24 h dosing interval in patients maintained on buprenorphine. , 2003, Drug and alcohol dependence.

[17]  R. Mattick,et al.  Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. , 2003, The Cochrane database of systematic reviews.

[18]  M. Langendam,et al.  The impact of harm-reduction-based methadone treatment on mortality among heroin users. , 2001, American journal of public health.

[19]  R. Stohler,et al.  Double-blind randomized trial of buprenorphine and methadone in opiate dependence. , 2001, Drug and alcohol dependence.

[20]  M. Stitzer,et al.  A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. , 2000, The New England journal of medicine.

[21]  G. Gessa,et al.  Buprenorphine: a controlled clinical trial in the treatment of opioid dependence. , 2000, Drug and alcohol dependence.

[22]  Katrin Baumgartner,et al.  World Drug Report 2000 , 2000 .

[23]  S. Kasper,et al.  Buprenorphine versus methadone maintenance for the treatment of opioid dependence. , 1999 .

[24]  D. Ladewig,et al.  Comparison of Buprenorphine and Methadone in the Treatment of Opioid Dependence , 1998, European Addiction Research.

[25]  E. Cone,et al.  Relationship of plasma buprenorphine and norbuprenorphine to withdrawal symptoms during dose induction, maintenance and withdrawal from sublingual buprenorphine. , 1998, Addiction.

[26]  L. Marsch.  The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. , 1998, Addiction.

[27]  W. Ling,et al.  Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial. , 1998, Addiction.

[28]  W. Ling,et al.  A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. , 1996, Archives of general psychiatry.

[29]  M. Stitzer,et al.  Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index. , 1996, Journal of clinical psychopharmacology.

[30]  M. Stitzer,et al.  A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence. , 1995, Drug and alcohol dependence.

[31]  J. Kurinczuk,et al.  The quantification of drug caused morbidity and mortality in Australia 1995 , 1995 .

[32]  K. Vranizan,et al.  HIV seroconversion in intravenous drug users in San Francisco, 1985–1990 , 1994, AIDS.

[33]  P. Stolley,et al.  Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. , 1993, Journal of acquired immune deficiency syndromes.

[34]  K. Powers,et al.  A 24-year follow-up of California narcotics addicts. , 1993, Archives of general psychiatry.

[35]  D. Ziedonis,et al.  Buprenorphine versus Methadone Maintenance for Opioid Dependence , 1993, The Journal of nervous and mental disease.

[36]  J. Jaffe,et al.  A controlled trial of buprenorphine treatment for opioid dependence. , 1992, JAMA.

[37]  L. Handelsman,et al.  Two new rating scales for opiate withdrawal. , 1987, The American journal of drug and alcohol abuse.

[38]  J. Strang.  ABUSE OF BUPRENORPHINE , 1985, The Lancet.

[39]  D. Nurco,et al.  The day-to-day criminality of heroin addicts in Baltimore--a study in the continuity of offence rates. , 1983, Drug and alcohol dependence.

[40]  L. Grönbladh,et al.  The Swedish methadone maintenance program: a controlled study. , 1981, Drug and alcohol dependence.

[41]  C. O'brien,et al.  Conditioned narcotic withdrawal in humans. , 1977, Science.

[42]  D. Steinberg.  Letter: Scientific medicine. , 1974, Lancet.